Feedback General Surgery

Oesophageal Carcinoma

Epidemiology

  • Most common in China and South Africa
  • Most common in men >45 years old
  • When patient presents with dysphagia it is usually advanced and inoperable

Etiology

  • Diet, deficiencies – vit A, C, riboflavin
  • Mycotoxin
  • Alcohol and tobacco
  • Achalasia cardia, oesophageal webs, Barrett’s oesophagus,  Plummer-Vinson’s syndrome
  • Corrosive strictures

Pathology

  • Most common in middle third (50%); lower third (33%); upper third (17%)
  • Squamous cell carcinoma (SCC) – arises from epithelial cells that line the oesophagus
  • Adenocarcinoma – arises from glandular cells in the lower third of the oesophagus
    • Lowest 3cm of oesophagus is lined by columnar cells so adenocarcinoma is more common here
    • Barrett’s oesophagus – metaplastic change in the mucosal cells lining the lower portion of the oesophagus, from normal stratified squamous epithelium to simple columnar epithelium. Predisposes to adenocarcinoma
  • Gross types – annular, ulcerative, fungating, polypoid, varicoid

Spread

  • Direct – lack of serosal layer in oesophagus favours local extension
    • In the upper third it spreads through muscular layer and adheres to left main bronchus, trachea, left recurrent laryngeal nerve, aorta
    • May perforate and cause mediastinitis
  • Lymphatic – by both lymphatic permeation and embolisation
    • Can cause satellite nodules elsewhere in oesophagus away from the main tumour
    • Above the neck it spreads to supraclavicular LNs
    • In thorax it spreads to paraoesophageal and tracheobroncheal LNs
    • In abdomen to celiac LNs
  • Blood – to liver, lungs, brain, bones

Clinical features

  • Recent onset of dysphagia – means that two thirds of lumen has been occluded
  • Regurgitation; anorexia, weight loss, cachexia
  • Pain – substernal or in abdomen
  • Liver secondaries, ascites
  • Bronchopneumonia, melaena
  • Features of bronco-oesophageal fistula when carcinoma is in the upper third of oesophagus
  • Troisier sign – Virchow’s node enlarged and palpable
  • Hoarseness – involvement of recurrent laryngeal n.
  • Hiccup – involvement of phrenic n.
  • Back pain – due to nodal spread (paraoesophageal/celiac nodes)

Investigations

  • Barium swallow – shouldering sign and irregular filling defect
  • Oesophagoscopy – to see lesion, extent and type
  • Biopsy – for histological typing
  • CXR – aspiration pneumonia, vocal cord palsy, fistula
  • Oesophageal endosonography – involvement of layers, nodes, left lobe of liver
  • CT – to look for local extension, nodal status, vascular infiltration, obliteration of mediastinal fat
  • US abdomen – liver and LN status
  • Blood test – Hct, ESR, LFT
  • Laparoscopy – peritoneal, liver, nodal spread. To take biopsy from different places

Treatment

Post cricoid tumours (SCC)

  • Radiotherapy
  • Pharyngolaryngectomy with gastric/colonic transposition

Upper third growth (SCC) – usually advanced with left recurrent laryngeal n. palsy

  • Radiotherapy
  • McKeown three phased oesophagectomy and anastomosis done in the neck
    • Oesophagus with growth removed and anastomosis between pharynx and stomach done in neck

Middle third growth (SCC)

  • Ivor Lewis operation – after laparotomy stomach is mobilised and pyloroplasty done
    • Partial oesophagectomy and oesophagogastric anastomosis is done in thorax

Lower third growth (SCC and adenocarcinoma)

  • Partial oesophagogastrectomy is done with oesophagogastric anastomosis

Post-operative management

  • Fluid and electrolyte management
  • Antibiotics and analgesia
  • Respiratory care, physiotherapy
  • Prevention of DVT – elevation, exercise, heparin
  • Monitor for bleeding, sepsis, leak O­2 saturation

Palliative treatment

  • Indications – to relieve pain and dysphagia; prevent bleeding and aspiration
  • External and intraluminal radiotherapy
  • Chemotherapy – cisplatin, methotrexate
  • Intubation – for trachea-oesophageal fistula
  • Endoscopic laser – to improve dysphagia
  • Self-expanding metal stents
  • Surgery – palliative gastric bypass
Feedback